This purified recombinant human biotinylated Fab recognizes ATAD2 in human samples.

Recombinant antibody characteristics include:
• Validation in Immunoprecipitation
• Superior lot-to-lot consistency
• Extremely high specificity and sensitivity
• Recombinant human biotinylated Fab
• Specific for ATAD2

ATAD2 is involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells. It may play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters.

Exceptional Consistency Saves You Time and Money
Recombinant antibodies are produced by transfection of mammalian cells with heavy and light chain antibody cDNAs. This provides you with the highest consistency between lots, eliminating the need to revalidate your assays for each lot.

High Specificity Means More Reliable Data
The recombinant technology employed in manufacture of the antibody assures greatest degree of reliability. Staining of nonspecific proteins is virtually eliminated while very high sensitivity is achieved. Life Technologies has validated this antibody in immunoprecipitation.

High Sensitivity Lets You Detect Low Levels of Target Protein
Recombinant antibodies demonstrate much higher sensitivity than ordinary antibodies. Proteins expressed in low levels can be detected with high specificity allowing you to use less of your precious samples than with ordinary antibodies.

Related Links:

Learn more about the superior performance of ABfinity™recombinant monoclonal antibodies.

See Life Technologies's full line of ABfinity™recombinant monoclonal antibodies.